Each option is supplied as a single vial, supporting flexible experimental design, batch consistency, and extended research applications
The satiety effects from the GLP-1 agonist can result in an increase in insulin production along with a decrease in food consumption, appetite, and hunger, which often leads to losing weight
Current options include participating in Phase 3 clinical trials at Canadian research sites (Vancouver, Toronto, Montreal, Calgary) or purchasing from research peptide suppliers for laboratory research purposes
(PubMed) Gebhardt R, Beck H
In a recent study published in the JAMA Network Open , a group of researchers evaluated the impact of exercise, glucagon-like peptide-1 receptor agonist (GLP-1 RA) liraglutide, and their combination on bone health at the hip, spine, and forearm following diet-induced weight loss in adults with obesity
Ivim Health specifically advertises Klarna, and Balanced Hormone Health offers Afterpay, Klarna, and CareCredit